Citius Oncology Other Current Liabilities

The latest other current liabilities for CTOR is $51M as of June 2026. That compares with $44M in the prior-year period — up 16.1% year over year. Investors often review this figure alongside Citius Oncology's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTOR's other current liabilities moved from $44M to $51M — a 16.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Citius Oncology's operating scale or balance-sheet position.

A other current liabilities figure of $51M for CTOR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CTOR's other current liabilities ($51M), review year-over-year change from $44M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.